CD8A and COVID-19: The percentage of CD57, KLRG1, CD56, NKG2A expressed by CD8+ T cells and late differentiated CD27-CD28-, EMRA CD8 subsets were not significantly different between the COVID-19+ and control cohort (Fig. 1B).